Recent accounts of debilitating skin conditions are drawing attention to a phenomenon known as Topical Steroid Withdrawal (TSW), a condition that has yet to be fully understood by the medical community. Many patients, like 21-year-old Bethany Gamble from Birmingham, have shared harrowing experiences of their skin deteriorating after years of reliance on steroid creams for eczema treatment. Their stories, amplified on social media, highlight the urgent need for further research into TSW, which is increasingly recognised but still often dismissed as merely a severe flare-up of eczema.
The Burden of Misdiagnosis
Bethany’s journey with eczema began in childhood, receiving steroid creams that initially helped manage her condition. However, at 18, she noticed a dramatic change as her eczema worsened into a full-body affliction that left her incapacitated. “My skin was hot, so inflamed and red,” she recalls, describing the pain that consumed her life. With her condition dismissed by healthcare professionals as merely eczema, Bethany felt unheard and invalidated, a sentiment echoed by many in the TSW community.
The hashtag #TSW has gained significant traction on platforms like TikTok, amassing over a billion views. This growing online movement has provided a platform for individuals to share their experiences of red, inflamed, and peeling skin, calling attention to a condition that remains inadequately researched. While some medical professionals acknowledge TSW as a debilitating reaction to steroid creams, others remain sceptical, asserting it is simply a severe manifestation of eczema.
Research Efforts Take Shape
In response to the increasing number of reported cases, Professor Sara Brown, a consultant dermatologist at the University of Edinburgh, has initiated groundbreaking research into TSW. Funded by the National Eczema Society, her study seeks to unravel the complexities of symptoms that appear to transcend traditional eczema patterns. “We’re seeing patterns in TSW that cannot be explained by what is known about eczema,” she notes, highlighting unusual symptoms such as thickened skin and sharply defined areas of redness.
The study aims to collect data from hundreds of participants across the UK, including skin biopsies and saliva samples, to better understand why certain individuals develop TSW while others do not. This research marks a significant step towards validating the experiences of those suffering from TSW and providing them with the recognition they deserve.
Unique Challenges of TSW Diagnosis
The symptoms of TSW can vary significantly based on skin tone, complicating diagnosis and treatment. Henry Jones, 22, from High Wycombe, describes his frustration after being repeatedly prescribed steroid creams despite knowing that his symptoms were atypical for eczema. “The more cream that went on, the worse I felt,” he explains, recounting his struggle that led to academic withdrawal and profound mental health challenges.
Karishma Leckraz, another participant in the study, faced similar hurdles, initially doubting her own experiences because they did not align with the predominantly white narratives she encountered online. “TSW took everything away from me,” she confesses, emphasising the psychological toll of her condition.
The National Eczema Society has expressed understanding of the predicament faced by patients. Andrew Procter, a representative, highlighted the dichotomy between the effectiveness of steroid creams for many and the disturbing reality of TSW for others, urging for more research and awareness.
Navigating Treatment Options
While TSW is now officially recognised by the Medicines and Health Regulatory Authority (MHRA) as a potential severe reaction to topical steroids, many GPs continue to prescribe these treatments as first-line therapy for eczema. The Royal London Hospital offers specialised clinics to address chronic skin diseases, providing alternative treatments such as immunosuppressants and psychological support to help manage the psychological impact of skin conditions.
Patients like Rebecca Ebbage, who stopped using steroids in July 2022, have turned to private clinics for treatments like Cold Atmospheric Plasma (CAP) therapy, which remains unapproved by the NHS. Rebecca’s experience, like many others, underscores the lengths to which individuals will go to reclaim their lives from the grips of TSW.
Why it Matters
The struggle against Topical Steroid Withdrawal highlights a critical gap in public health regarding the management and treatment of eczema. As more individuals like Bethany, Henry, and Karishma share their stories, it becomes apparent that the medical community must take these accounts seriously and engage in rigorous research to understand the mechanisms behind TSW. This emerging condition not only devastates personal lives but also poses significant public health challenges, necessitating a re-evaluation of treatment protocols and greater awareness among healthcare providers. Addressing TSW is not merely about improving individual outcomes; it represents a broader imperative to ensure that patients are heard and validated in their health journeys.
